U.S. markets closed

Age-Related Macular Degeneration Markets, Pipeline, Drugs and Companies: 2016-2024

DUBLIN, May 13, 2020 /PRNewswire/ -- The "Global Age-Related Macular Degeneration Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This research report provides comprehensive insights into the Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. The research analyzes and forecasts the Age-Related Macular Degeneration market size and drug sales. It also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.

Research Scope

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Age-Related Macular Degeneration by countries
  • Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
  • Age-Related Macular Degeneration drugs sales: Find out the sales value for Age-Related Macular Degeneration drugs by countries
  • Age-Related Macular Degeneration market valuations: Find out the market size for Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research

  • Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze Age-Related Macular Degeneration drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered

1. Age-Related Macular Degeneration Treatment Options

2. Age-Related Macular Degeneration Pipeline Insights
2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Age-Related Macular Degeneration Epidemiology Analysis by Countries

4. US Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Age-Related Macular Degeneration in US
4.2. US Age-Related Macular Degeneration Market Size & Forecast
4.3. US Age-Related Macular Degeneration Drugs Sales & Forecast
4.4. US Age-Related Macular Degeneration Market Share Analysis

5. Germany Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Age-Related Macular Degeneration in Germany
5.2. Germany Age-Related Macular Degeneration Market Size & Forecast
5.3. Germany Age-Related Macular Degeneration Drugs Sales Forecast
5.4. Germany Age-Related Macular Degeneration Market Share Analysis

6. France Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Age-Related Macular Degeneration in France
6.2. France Age-Related Macular Degeneration Market Size & Forecast
6.3. France Age-Related Macular Degeneration Product Sales Forecast
6.4. France Age-Related Macular Degeneration Market Share Analysis

7. Italy Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Age-Related Macular Degeneration in Italy
7.2. Italy Age-Related Macular Degeneration Market Size & Forecast
7.3. Italy Age-Related Macular Degeneration Product Sales Forecast
7.4. Italy Age-Related Macular Degeneration Market Share Analysis

8. Spain Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Age-Related Macular Degeneration in Spain
8.2. Spain Age-Related Macular Degeneration Market Size & Forecast
8.3. Spain Age-Related Macular Degeneration Product Sales Forecast
8.4. Spain Age-Related Macular Degeneration Market Share Analysis

9. UK Age-Related Macular Degeneration Market Insights
9.1. Marketed Drugs for Age-Related Macular Degeneration in UK
9.2. UK Age-Related Macular Degeneration Market Size & Forecast
9.3. UK Age-Related Macular Degeneration Product Sales Forecast
9.4. UK Age-Related Macular Degeneration Market Share Analysis

10. Europe Age-Related Macular Degeneration Market Insights
10.1. Europe Age-Related Macular Degeneration Market Size & Forecast
10.2. Europe Age-Related Macular Degeneration Product Sales Forecast
10.3. Europe Age-Related Macular Degeneration Market Share Analysis

11. Japan Age-Related Macular Degeneration Market Insights
11.1. Marketed Drugs for Age-Related Macular Degeneration in Japan
11.2. Japan Age-Related Macular Degeneration Market Size & Forecast
11.3. Japan Age-Related Macular Degeneration Product Sales Forecast
11.4. Japan Age-Related Macular Degeneration Market Share Analysis

12. Global Age-Related Macular Degeneration Market Insights
12.1. Global Age-Related Macular Degeneration Market Size & Forecast
12.2. Global Age-Related Macular Degeneration Product Sales Forecast
12.3. Global Age-Related Macular Degeneration Market Share Analysis

For more information about this report visit https://www.researchandmarkets.com/r/e72kf9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/age-related-macular-degeneration-markets-pipeline-drugs-and-companies-2016-2024-301058662.html

SOURCE Research and Markets